6 Red Days In A Row: Coupang Stock Is Down 15%
Today’s big story: Anthropic IPO: Priced For 2031, Or 2036?
Coupang (CPNG) stock has fallen for 6 consecutive trading days, losing 14.7% over that stretch. That erased about $4.3 billion from the company’s market value, which now stands at about $25.1 billion. The stock closed at $14.00 on Tuesday, November 17, 50.3% below its 52-week high of $28.16 and 1.8% above its low of $13.75.

CPNG Versus The S&P 500
Returns for CPNG and the S&P 500 over the streak and the periods around it, all ending Tuesday, November 17 and including dividends:
| Return Period | CPNG | S&P 500 |
|---|---|---|
| 1 Day | -2.4% | -1.0% |
| 6 Days (Current Streak) | -14.7% | -2.7% |
| 1 Month (21 Trading Days) | -2.4% | -4.5% |
| 3 Months (63 Trading Days) | -16.0% | -4.5% |
| Year To Date | -40.7% | 8.3% |
| 1 Year (252 Trading Days) | -50.4% | 10.3% |
A Stock-Specific Slide, Or A Market Move?
The market explains little of this: the S&P 500 lost 2.7% over the same 6 sessions, including dividends, against Coupang’s -14.7%. Over the past three months the stock is down 16.0%, a window that includes the streak; over the other 57 sessions of that window it was essentially flat (-1.4%).
Is The Business As Weak As The Stock?
On the fundamentals, revenue grew 7.4% over the last twelve months, against a median of 7.7% for S&P 500 Consumer Discretionary stocks; and its operating margin is -3.4%, versus a median of 14.9%. Coupang does not have positive trailing earnings, so there is no meaningful price-to-earnings multiple to compare. The fundamentals give the sellers some support: revenue growth below the median and an operating loss.
A slide like this raises an obvious follow-up: which marked-down stocks are actually worth buying? Our Buy the Dip screen runs that test every day, flagging beaten-down names whose fundamentals still hold up.
For anyone who would rather back the theme than one company, a consumer discretionary ETF like XLY holds the whole group, not just this stock. It is still a concentrated bet on one theme, which is the gap the portfolio below is built to close.
Falling Prices Test Conviction. Rules Do Not Flinch
A losing streak forces a choice on every holder: sell into weakness, average down, or freeze. All three are emotional answers to what should be an analytical question, and decisions made that way tend to be expensive ones.
The Trefis High Quality (HQ) Portfolio takes the emotion out: about 30 quality businesses screened for the fundamentals that survive bad stretches, held and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Let the rules decide, not the tape.